In a groundbreaking discovery, a team of researchers has found that a common food additive has enabled the mass production of brain organoids, opening up new possibilities for studying brain development and diseases on a larger scale.
For nearly a decade, the Stanford Brain Organogenesis Program has been at the forefront of a revolutionary approach to studying the brain. Instead of relying on intact brain tissue, the team grows three-dimensional brain-like structures called organoids in the lab using stem cells, allowing them to model human neural development and disorders.
One of the primary challenges faced by the researchers was the limited scalability of their organoid production. To delve deeper into brain development, understand neurodevelopmental disorders, and test new therapies effectively, they needed the ability to generate thousands of organoids simultaneously, each with consistent characteristics.
The main obstacle to scaling up organoid production stemmed from the tendency of these structures to clump together, making it difficult to create a large number of organoids with uniform size and shape. This limitation hindered the researchers from conducting experiments at the desired scale and consistency.
To tackle this challenge, a team of neuroscientists and engineers, led by experts like Sergiu Pasca and Sarah Heilshorn, identified a simple yet effective solution: xanthan gum, a widely used food additive. Their research, published in Nature Biomedical Engineering, showcased how xanthan gum could prevent organoids from fusing together, allowing for the production of thousands of organoids with consistent quality.
By implementing this innovative approach, the researchers were able to address real-world issues, such as testing the effects of FDA-approved drugs on brain development. This method enabled them to efficiently screen hundreds of drugs for potential growth defects, providing valuable insights into the impact of these drugs on brain development.
Moving forward, the team aims to leverage this technique to advance research on neuropsychiatric disorders like autism, epilepsy, and schizophrenia. By scaling up organoid production, they hope to make significant strides in understanding and potentially treating these complex conditions.
The success of this research highlights the importance of interdisciplinary collaboration and innovative technologies in advancing neuroscience. By uniting experts from various fields and leveraging accessible materials like xanthan gum, the researchers were able to overcome a longstanding challenge in brain organoid research and unlock new possibilities for studying the brain at scale.
Key Takeaways:
– A common food additive, xanthan gum, has enabled the mass production of brain organoids, revolutionizing neuroscience research.
– This breakthrough has allowed researchers to generate thousands of organoids simultaneously, facilitating the study of brain development and diseases at a larger scale.
– By using xanthan gum to prevent organoid fusion, the team was able to efficiently screen FDA-approved drugs for potential growth defects, showcasing the practical applications of this technique.
– The scalability of organoid production opens up new avenues for research on neuropsychiatric disorders, offering hope for improved understanding and treatment of conditions like autism, epilepsy, and schizophrenia.
Tags: scale up, organoids, gene therapy
Read more on scitechdaily.com
